Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
103.12
+0.09 (0.09%)
At close: Oct 27, 2025, 4:00 PM EDT
103.12
0.00 (0.00%)
After-hours: Oct 27, 2025, 4:10 PM EDT
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $2.08B in the quarter ending June 30, 2025, with 6.97% growth. This brings the company's revenue in the last twelve months to $7.83B, up 4.11% year-over-year. In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth.
Revenue (ttm)
$7.83B
Revenue Growth
+4.11%
P/S Ratio
2.63
Revenue / Employee
$460,812
Employees
17,000
Market Cap
20.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
| Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
| Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
| Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
| Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ZBH News
- 6 days ago - Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting - PRNewsWire
- 15 days ago - Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A Buy - Seeking Alpha
- 19 days ago - Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases - PRNewsWire
- 20 days ago - Zimmer Biomet Completes Acquisition of Monogram Technologies - PRNewsWire
- 21 days ago - I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance - Business Wire
- 24 days ago - Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System - PRNewsWire
- 6 weeks ago - Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha